Paraoxonases in Inflammation, Infection, and Toxicology

*** This series does not include back cover copy. ***

ApoE Mimetic Peptide Reduces Plasma Lipid Hydroperoxide Content with a Concomitant Increase in HDL Paraoxonase Activity. - Interrelationships Between Paraoxonase-1 and Monocyte Chemoattractant Protein-1 in the Regulation of Hepatic Inflammation. - Biomarkers of Sensitivity and Exposure in Washington State Pesticide Handlers. - Paraoxonase 1 Status as a Risk Factor for Disease or Exposure. - Engineering Human PON1 in an E. coli Expression System. - The Toxicity of Mixtures of Specific Organophosphate Compounds is Modulated by Paraoxonase 1 Status. - Identification and Characterization of Biomarkers of Organophosphorus Exposures in Humans. - Temporal and Tissue-Specific Patterns of Pon3 Expression in Mouse: In situ Hybridization Analysis. - PON1 and Oxidative Stress in Human Sepsis and an Animal Model of Sepsis. - Paraoxonase 1 Attenuates Human Plaque Atherogenicity: Relevance to the Enzyme Lactonase Activity. - The Role of Paraoxonase 1 in the Detoxification of Homocysteine Thiolactone. - Alteration of PON1 Activity in Adult and Childhood Obesity and Its Relation to Adipokine Levels. - Anti-Inflammatory Properties of Paraoxonase-1 in Atherosclerosis. - Paraoxonase 1 Interactions with HDL, Antioxidants and Macrophages Regulate Atherogenesis A Protective Role for HDL Phospholipids. - The Effect of HDL Mimetic Peptide 4F on PON1. - The Contribution of High Density Lipoprotein Apolipoproteins and Derivatives to Serum Paraoxonase-1 Activity and Function. - Paraoxonase 1, Quorum Sensing, and P. aeruginosa Infection: A Novel Model.